Browsing by Yonsei Author : Cho, Byoung Chul

eperson profile image
Name:
Cho, Byoung Chul [조병철]
orcid http://orcid.org/0000-0002-5562-270X
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (7401747804)

Keyword Cloud

Researcher Network

Showing results 151 to 200 of 265

This table browses all dspace content
Issue DateTitleJournal Title
2017Rare Incidence of ROS1 Rearrangement in Cholangiocarcinoma CANCER RESEARCH AND TREATMENT
2017Optimal Adjuvant Treatment for Curatively Resected Thoracic Esophageal Squamous Cell Carcinoma: A Radiotherapy Perspective CANCER RESEARCH AND TREATMENT
2016Clinical course of stage IV invasive mucinous adenocarcinoma of the lungLUNG CANCER
2016PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients SCIENTIFIC REPORTS
2016Alteration status and prognostic value of MET in head and neck squamous cell carcinoma JOURNAL OF CANCER
2016Induction docetaxel and S-1 followed by concomitant radiotherapy with low-dose daily cisplatin in locally advanced head and neck carcinomaHEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
2016Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus ONCOTARGET
2016A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancerCANCER CHEMOTHERAPY AND PHARMACOLOGY
2016ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer modelsLUNG CANCER
2016Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative ONCOTARGET
2016Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy ONCOGENESIS
2016Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase 2 studyCANCER
2016Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trialLANCET ONCOLOGY
2016Targeted sequencing identifies genetic alterations that confer primary resistance to EGFR tyrosine kinase inhibitor (Korean Lung Cancer Consortium) ONCOTARGET
2016The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma CANCER RESEARCH AND TREATMENT
2016PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma. ONCOTARGET
2016Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status.LUNG CANCER
2016A Case of ALK-Rearranged Adenocarcinoma with Small Cell Carcinoma-Like Transformation and Resistance to CrizotinibJOURNAL OF THORACIC ONCOLOGY
2016Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck SCIENTIFIC REPORTS
2016A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806)LUNG CANCER
2016Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancerLUNG CANCER
2016Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases From Lung Adenocarcinoma: Early Response and Dosimetric Evaluation.TECHNOLOGY IN CANCER RESEARCH & TREATMENT
2016Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapyPHARMACOGENETICS AND GENOMICS
2015Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma ONCOTARGET
2015Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinomaCANCER
2015Cabazitaxel Versus Topotecan in Patients with Small-Cell Lung Cancer with Progressive Disease During or After First-Line Platinum-Based Chemotherapy JOURNAL OF THORACIC ONCOLOGY
2015Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma MOLECULAR CANCER THERAPEUTICS
2015Mutational landscapes of tongue carcinoma reveal recurrent mutations in genes of therapeutic and prognostic relevance GENOME MEDICINE
2015Reduced expression of EI24 confers resistance to gefitinib through IGF-1R signaling in PC9 NSCLC cellsLUNG CANCER
2015Lack of ROS1 Gene Rearrangement in Glioblastoma Multiforme PLOS ONE
2015Nivolumab in NSCLC: latest evidence and clinical potentialTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2015Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790MNATURE MEDICINE
2015An open label, multicenter, phase II study of dovitinib in advanced thyroid cancerEUROPEAN JOURNAL OF CANCER
2015The regulation of glucose-6-phosphatase and phosphoenolpyruvate carboxykinase by autophagy in low-glycolytic hepatocellular carcinoma cellsBIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
2015The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancerLUNG CANCER
2015Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma. ONCOTARGET
2015Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neckCLINICAL CANCER RESEARCH
2014Safety and efficacy of dacomitinib in korean patients with KRAS wild-type advanced non-small-cell lung cancer refractory to chemotherapy and erlotinib or gefitinib: a phase I/II trial.JOURNAL OF THORACIC ONCOLOGY
2014Tumor MET expression profile predicts the outcome of non-small cell lung cancer patients receiving epidermal growth factor receptor tyrosine kinase inhibitorsTHORACIC CANCER
2014Phase II Study of Afatinib as Third-Line Treatment for Patients in Korea With Stage IIIB/IV Non-Small Cell Lung Cancer Harboring Wild-Type EGFRONCOLOGIST
2014Immunotherapy in the treatment of non-small cell lung cancerLUNG CANCER
2014Screening of ROS1 rearrangements in lung adenocarcinoma by immunohistochemistry and comparison with ALK rearrangements PLOS ONE
2014Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers GENOME MEDICINE
2014Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutationsLUNG CANCER
2014A Single-Tube Multiplexed Assay for Detecting ALK, ROS1, and RET Fusions in Lung CancerJOURNAL OF MOLECULAR DIAGNOSTICS
2014Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinomaLUNG CANCER
2014A prospective phase II trial of s-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancerCANCER CHEMOTHERAPY AND PHARMACOLOGY
2014Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinomaLUNG CANCER
2013A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypesANNALS OF ONCOLOGY
2013Glycolysis Inhibition Sensitizes Non–Small Cell Lung Cancer with T790M Mutation to Irreversible EGFR Inhibitors via Translational Suppression of Mcl-1 by AMPK ActivationMOLECULAR CANCER THERAPEUTICS

Browse

Links